S&P 500   4,569.92 (+0.33%)
DOW   35,475.63 (+0.17%)
QQQ   391.57 (+0.35%)
AAPL   190.69 (+0.15%)
MSFT   379.22 (-0.91%)
META   332.04 (-2.05%)
GOOGL   135.77 (-1.04%)
AMZN   146.80 (-0.16%)
TSLA   249.74 (+1.22%)
NVDA   482.61 (+0.92%)
NIO   7.29 (+1.11%)
BABA   75.26 (-1.93%)
AMD   125.03 (+2.48%)
T   16.22 (+0.25%)
F   10.77 (+3.86%)
MU   78.11 (+2.61%)
CGC   0.55 (+2.44%)
GE   119.01 (+0.13%)
DIS   91.59 (-0.98%)
AMC   7.05 (+5.22%)
PFE   30.12 (+1.45%)
PYPL   58.75 (+0.48%)
XOM   103.39 (-0.49%)
S&P 500   4,569.92 (+0.33%)
DOW   35,475.63 (+0.17%)
QQQ   391.57 (+0.35%)
AAPL   190.69 (+0.15%)
MSFT   379.22 (-0.91%)
META   332.04 (-2.05%)
GOOGL   135.77 (-1.04%)
AMZN   146.80 (-0.16%)
TSLA   249.74 (+1.22%)
NVDA   482.61 (+0.92%)
NIO   7.29 (+1.11%)
BABA   75.26 (-1.93%)
AMD   125.03 (+2.48%)
T   16.22 (+0.25%)
F   10.77 (+3.86%)
MU   78.11 (+2.61%)
CGC   0.55 (+2.44%)
GE   119.01 (+0.13%)
DIS   91.59 (-0.98%)
AMC   7.05 (+5.22%)
PFE   30.12 (+1.45%)
PYPL   58.75 (+0.48%)
XOM   103.39 (-0.49%)
S&P 500   4,569.92 (+0.33%)
DOW   35,475.63 (+0.17%)
QQQ   391.57 (+0.35%)
AAPL   190.69 (+0.15%)
MSFT   379.22 (-0.91%)
META   332.04 (-2.05%)
GOOGL   135.77 (-1.04%)
AMZN   146.80 (-0.16%)
TSLA   249.74 (+1.22%)
NVDA   482.61 (+0.92%)
NIO   7.29 (+1.11%)
BABA   75.26 (-1.93%)
AMD   125.03 (+2.48%)
T   16.22 (+0.25%)
F   10.77 (+3.86%)
MU   78.11 (+2.61%)
CGC   0.55 (+2.44%)
GE   119.01 (+0.13%)
DIS   91.59 (-0.98%)
AMC   7.05 (+5.22%)
PFE   30.12 (+1.45%)
PYPL   58.75 (+0.48%)
XOM   103.39 (-0.49%)
S&P 500   4,569.92 (+0.33%)
DOW   35,475.63 (+0.17%)
QQQ   391.57 (+0.35%)
AAPL   190.69 (+0.15%)
MSFT   379.22 (-0.91%)
META   332.04 (-2.05%)
GOOGL   135.77 (-1.04%)
AMZN   146.80 (-0.16%)
TSLA   249.74 (+1.22%)
NVDA   482.61 (+0.92%)
NIO   7.29 (+1.11%)
BABA   75.26 (-1.93%)
AMD   125.03 (+2.48%)
T   16.22 (+0.25%)
F   10.77 (+3.86%)
MU   78.11 (+2.61%)
CGC   0.55 (+2.44%)
GE   119.01 (+0.13%)
DIS   91.59 (-0.98%)
AMC   7.05 (+5.22%)
PFE   30.12 (+1.45%)
PYPL   58.75 (+0.48%)
XOM   103.39 (-0.49%)

Amedisys (AMED) Competitors

$93.94
-0.07 (-0.07%)
(As of 10:45 AM ET)
Compare
Today's Range
$93.86
$94.20
50-Day Range
$91.15
$94.09
52-Week Range
$69.36
$106.01
Volume
35,261 shs
Average Volume
480,107 shs
Market Capitalization
$3.07 billion
P/E Ratio
1,342.19
Dividend Yield
N/A
Price Target
$103.55

AMED vs. ADUS, AHCO, OPCH, GKOS, ARWR, IART, PDCO, CYTK, DNA, and ITGR

Should you be buying Amedisys stock or one of its competitors? The main competitors of Amedisys include Addus HomeCare (ADUS), AdaptHealth (AHCO), Option Care Health (OPCH), Glaukos (GKOS), Arrowhead Pharmaceuticals (ARWR), Integra LifeSciences (IART), Patterson Companies (PDCO), Cytokinetics (CYTK), Ginkgo Bioworks (DNA), and Integer (ITGR). These companies are all part of the "medical" sector.

Amedisys vs.

Addus HomeCare (NASDAQ:ADUS) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends.

Amedisys received 187 more outperform votes than Addus HomeCare when rated by MarketBeat users. However, 66.90% of users gave Addus HomeCare an outperform vote while only 58.19% of users gave Amedisys an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
289
66.90%
Underperform Votes
143
33.10%
AmedisysOutperform Votes
476
58.19%
Underperform Votes
342
41.81%

95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 95.7% of Amedisys shares are held by institutional investors. 4.4% of Addus HomeCare shares are held by insiders. Comparatively, 1.8% of Amedisys shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Addus HomeCare presently has a consensus target price of $107.50, indicating a potential upside of 20.57%. Amedisys has a consensus target price of $103.55, indicating a potential upside of 10.14%. Given Amedisys' stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Amedisys.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Amedisys
0 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.18

Amedisys has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$951.12M1.52$46.03M$3.5525.12
Amedisys$2.22B1.38$118.61M$0.071,343.19

Addus HomeCare has a net margin of 5.61% compared to Addus HomeCare's net margin of 0.12%. Addus HomeCare's return on equity of 13.45% beat Amedisys' return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare5.61% 9.39% 6.45%
Amedisys 0.12%13.45%7.45%

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

In the previous week, Amedisys had 3 more articles in the media than Addus HomeCare. MarketBeat recorded 5 mentions for Amedisys and 2 mentions for Addus HomeCare. Amedisys' average media sentiment score of 1.32 beat Addus HomeCare's score of 0.37 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Amedisys
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Addus HomeCare and Amedisys tied by winning 9 of the 18 factors compared between the two stocks.


Get Amedisys News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMED vs. The Competition

MetricAmedisysHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$3.07B$3.37B$4.52B$6.70B
Dividend YieldN/A0.28%2.97%6.96%
P/E Ratio1,343.19356.33130.8213.53
Price / Sales1.381.502,524.7476.10
Price / Cash12.9414.4521.8622.84
Price / Book2.764.053.764.47
Net Income$118.61M-$4.65M$122.57M$176.27M
7 Day Performance0.13%3.73%1.08%1.15%
1 Month Performance2.84%29.01%13.47%9.57%
1 Year Performance6.33%38.98%5.61%2.60%

Amedisys Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
2.5512 of 5 stars
$87.34
-0.4%
$107.50
+23.1%
-17.6%$1.42B$1.03B24.6033,182Positive News
AHCO
AdaptHealth
2.2379 of 5 stars
$8.32
-2.3%
$13.83
+66.2%
-59.0%$1.13B$3.08B-2.4310,900
OPCH
Option Care Health
2.2996 of 5 stars
$29.94
+0.8%
$37.17
+24.1%
+4.9%$5.30B$4.21B21.238,058Positive News
GKOS
Glaukos
2.1881 of 5 stars
$62.87
-1.6%
$81.22
+29.2%
+28.6%$3.07B$303.57M-23.37783Analyst Report
Short Interest ↑
News Coverage
Gap Up
ARWR
Arrowhead Pharmaceuticals
1.9433 of 5 stars
$28.37
-1.8%
$54.53
+92.2%
+3.3%$3.04B$256.21M-16.59397Short Interest ↑
IART
Integra LifeSciences
2.1837 of 5 stars
$38.66
-0.1%
$45.63
+18.0%
-26.4%$3.02B$1.54B31.953,722
PDCO
Patterson Companies
2.4855 of 5 stars
$32.28
+0.8%
$36.17
+12.0%
+10.8%$3.09B$6.52B14.747,600Earnings Report
Analyst Report
Short Interest ↑
Gap Down
CYTK
Cytokinetics
2.316 of 5 stars
$31.74
-1.8%
$59.87
+88.6%
-22.1%$3.11B$7.82M-5.75409Negative News
DNA
Ginkgo Bioworks
1.772 of 5 stars
$1.43
-6.6%
$3.19
+123.7%
-22.0%$2.99B$314.99M-3.101,292Insider Selling
Short Interest ↓
ITGR
Integer
1.7749 of 5 stars
$89.42
-0.3%
$93.83
+4.9%
+25.6%$2.98B$1.56B36.5010,000Positive News

Related Companies and Tools

This page (NASDAQ:AMED) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -